Target type: molecularfunction
Binding to spectrin, a protein that is the major constituent of the erythrocyte cytoskeletal network. It associates with band 4.1 (see band protein) and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane. It is composed of nonhomologous chains, alpha and beta, which aggregate side-to-side in an antiparallel fashion to form dimers, tetramers, and higher polymers. [GOC:mah, ISBN:0198506732]
Spectrin binding is a molecular interaction that plays a crucial role in maintaining the structural integrity and function of various cellular components, particularly in the context of the cytoskeleton. Spectrins are a family of elongated, fibrous proteins that form tetramers, which then assemble into a complex network associated with the plasma membrane. These networks provide structural support, regulate membrane organization and dynamics, and facilitate interactions with other cytoskeletal components.
Spectrin binding involves the interaction of a spectrin molecule with another protein or molecule. The binding site on spectrin can vary depending on the interacting partner, but typically involves specific protein domains within the spectrin molecule, often located at the N-terminus or the C-terminus.
The molecular mechanisms underlying spectrin binding are diverse and involve a combination of non-covalent interactions, including electrostatic interactions, hydrogen bonding, and hydrophobic interactions. These interactions contribute to the specificity and strength of the binding event.
The functional implications of spectrin binding are wide-ranging and include:
- **Cell Shape and Stability:** Spectrin binding to actin filaments and other cytoskeletal proteins contributes to the structural organization of the cell, maintaining its shape and integrity.
- **Membrane Organization:** Spectrins play a crucial role in organizing and anchoring membrane proteins, including ion channels, receptors, and enzymes, to specific regions of the cell membrane.
- **Signal Transduction:** Spectrin interactions with signaling proteins can influence cellular signaling pathways, regulating processes like cell growth, differentiation, and migration.
- **Cellular Movement:** Spectrin binding is involved in the dynamic reorganization of the cytoskeleton, facilitating cell migration and movement.
- **Red Blood Cell Structure and Function:** In erythrocytes (red blood cells), spectrin forms a complex network that underlies the plasma membrane, providing the cell with its characteristic biconcave shape and flexibility, essential for efficient oxygen transport.
In summary, spectrin binding is a fundamental molecular interaction with diverse functional consequences, playing a critical role in maintaining cellular structure, function, and signaling. Spectrin's ability to bind to a wide range of proteins underscores its importance in regulating various cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | A retinal rod rhodopsin-sensitive cGMP 3,5-cyclic phosphodiesterase subunit gamma that is encoded in the genome of human. [PRO:DNx, UniProtKB:P18545] | Homo sapiens (human) |
Receptor-type tyrosine-protein phosphatase C | A receptor-type tyrosine-protein phosphatase C that is encoded in the genome of human. [PRO:CNA, UniProtKB:P08575] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4-hydroxyphenylglyoxylic acid | 4-hydroxyphenylglyoxylate : Conjugate base of 4-hydroxyphenylglyoxylic acid. 4-hydroxyphenylglyoxylic acid: RN given refers to parent cpd | phenols | |
5-iodo-2-(oxaloamino)benzoic acid | organoiodine compound | ||
dipyridamole | dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots. Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
9,10-phenanthrenequinone | 9,10-phenanthrenequinone: structure | phenanthrenes | |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
1,2-naphthoquinone | 1,2-naphthoquinone : The parent structure of the family of 1,2-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 2 of the naphthalene ring. It is a metabolite of naphthalene and is found in diesel exhaust particles. naphthalene-1,2-dione: structure given in first source | 1,2-naphthoquinones | aryl hydrocarbon receptor agonist; carcinogenic agent |
tadalafil | benzodioxoles; pyrazinopyridoindole | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent | |
cryptotanshinone | cryptotanshinone: from Salvia miltiorrhiza | abietane diterpenoid | anticoronaviral agent |
2-(oxaloamino)benzoic acid | (oxaloamino)benzoic acid | ||
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid | 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source | ||
variabilin | variabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source | ||
sildenafil | sildenafil : A pyrazolo[4,3-d]pyrimidin-7-one having a methyl substituent at the 1-position, a propyl substituent at the 3-position and a 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl group at the 5-position. | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
zaprinast | zaprinast: anaphylaxis inhibitor; structure | triazolopyrimidines | |
vardenafil | vardenafil : The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine. | imidazotriazine; N-alkylpiperazine; N-sulfonylpiperazine | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |